SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-20-011453
Filing Date
2020-06-19
Accepted
2020-06-19 10:36:46
Documents
2

Document Format Files

Seq Description Document Type Size
1 sc13g.htm SC 13G 161900
2 ex1.htm EX-1 9504
  Complete submission text file 0001493152-20-011453.txt   173220
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Subject) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-37761 | Film No.: 20974581
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 412 WEST 15TH STREET 9TH FLOOR NEW YORK NY 10011
Business Address 412 WEST 15TH STREET 9TH FLOOR NEW YORK NY 10011 646-597-6980
RTW INVESTMENTS, LP (Filed by) CIK: 0001493215 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G